(Q36535669)

14 August 2017

1 reference

title

Death ligands and autoimmune demyelination (English)

1 reference

14 August 2017

3

Frauke Zipp

1 reference

14 August 2017

Orhan Aktas

1

1 reference

14 August 2017

Timour Prozorovski

series ordinal

2

1 reference

14 August 2017

publication date

1 August 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

12

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

305-316

1 reference

Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Direct ex vivo analysis of activated, Fas-sensitive autoreactive T cells in human autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Multiple sclerosis: Fas signaling in oligodendrocyte cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Upregulation and colocalization of p75 and Nav1.8 in Purkinje neurons in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Lymphotoxin/light, lymphoid microenvironments and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

New concepts in the immunopathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

CD27-CD70 interactions regulate B-cell activation by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Signaling of gp34 (OX40 ligand) induces vascular endothelial cells to produce a CC chemokine RANTES/CCL5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Immunological aspects of demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

BAFF augments certain Th1-associated inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Na+ channel expression along axons in multiple sclerosis and its models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858405285208

21 January 2018

Identifiers

DOI

10.1177/1073858405285208

1 reference

14 August 2017

1 reference